Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 229

1.

High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.

Wang L, Gu F, Liu CY, Wang RJ, Li J, Xu JY.

Tumour Biol. 2013 Apr;34(2):853-8. doi: 10.1007/s13277-012-0617-7. Epub 2012 Dec 16.

PMID:
23242609
[PubMed - indexed for MEDLINE]
2.

Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.

Xue YZ, Sheng YY, Liu ZL, Wei ZQ, Cao HY, Wu YM, Lu YF, Yu LH, Li JP, Li ZS.

Tumour Biol. 2013 Apr;34(2):895-9. doi: 10.1007/s13277-012-0624-8. Epub 2012 Dec 18.

PMID:
23247867
[PubMed - indexed for MEDLINE]
3.

Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.

Xia JT, Wang H, Liang LJ, Peng BG, Wu ZF, Chen LZ, Xue L, Li Z, Li W.

Pancreas. 2012 May;41(4):629-35. doi: 10.1097/MPA.0b013e31823bcef2.

PMID:
22249132
[PubMed - indexed for MEDLINE]
4.

High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.

Wei LX, Zhou RS, Xu HF, Wang JY, Yuan MH.

Tumour Biol. 2013 Apr;34(2):941-6. doi: 10.1007/s13277-012-0629-3. Epub 2012 Dec 22.

PMID:
23264086
[PubMed - indexed for MEDLINE]
5.

Expression of UbcH10 in pancreatic ductal adenocarcinoma and its correlation with prognosis.

Zhao ZK, Wu WG, Chen L, Dong P, Gu J, Mu JS, Yang JH, Liu YB.

Tumour Biol. 2013 Jun;34(3):1473-7. doi: 10.1007/s13277-013-0671-9. Epub 2013 Jan 26.

PMID:
23355337
[PubMed - indexed for MEDLINE]
6.

MTA2 expression is a novel prognostic marker for pancreatic ductal adenocarcinoma.

Chen DW, Fan YF, Li J, Jiang XX.

Tumour Biol. 2013 Jun;34(3):1553-7. doi: 10.1007/s13277-013-0685-3. Epub 2013 Feb 12.

PMID:
23400716
[PubMed - indexed for MEDLINE]
7.

Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.

Jin A, Xu Y, Liu S, Jin T, Li Z, Jin H, Lin L, Lin Z.

Exp Mol Pathol. 2014 Feb;96(1):54-60. doi: 10.1016/j.yexmp.2013.11.003. Epub 2013 Nov 18.

PMID:
24263054
[PubMed - indexed for MEDLINE]
8.

Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.

Guo S, Jing W, Hu X, Zhou X, Liu L, Zhu M, Yin F, Chen R, Zhao J, Guo Y.

Int J Cancer. 2014 Mar 15;134(6):1369-78. doi: 10.1002/ijc.28471. Epub 2013 Oct 3.

PMID:
24037692
[PubMed - indexed for MEDLINE]
9.

CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.

Wang L, Gu F, Ma N, Zhang L, Bian JM, Cao HY.

Tumour Biol. 2013 Aug;34(4):2309-13. doi: 10.1007/s13277-013-0775-2. Epub 2013 Apr 9.

PMID:
23568706
[PubMed - indexed for MEDLINE]
10.

Prostate-specific membrane antigen as a marker of pancreatic cancer cells.

Ren H, Zhang H, Wang X, Liu J, Yuan Z, Hao J.

Med Oncol. 2014 Mar;31(3):857. doi: 10.1007/s12032-014-0857-z. Epub 2014 Jan 30.

PMID:
24477651
[PubMed - indexed for MEDLINE]
11.

Expression of galectin-3 in pancreatic ductal adenocarcinoma.

Gaida MM, Bach ST, Günther F, Baseras B, Tschaharganeh DF, Welsch T, Felix K, Bergmann F, Hänsch GM, Wente MN.

Pathol Oncol Res. 2012 Apr;18(2):299-307. doi: 10.1007/s12253-011-9444-1. Epub 2011 Sep 12.

PMID:
21910036
[PubMed - indexed for MEDLINE]
12.

DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinoma.

Xue YZ, Wu TL, Wu YM, Sheng YY, Wei ZQ, Lu YF, Yu LH, Li JP, Li ZS.

Tumour Biol. 2013 Oct;34(5):2857-61. doi: 10.1007/s13277-013-0846-4. Epub 2013 May 17.

PMID:
23681804
[PubMed - indexed for MEDLINE]
13.

Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.

Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H.

Mod Pathol. 2012 Jan;25(1):112-21. doi: 10.1038/modpathol.2011.142. Epub 2011 Oct 7.

PMID:
21983937
[PubMed - indexed for MEDLINE]
Free Article
14.

Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer.

Hiroshima Y, Nakamura F, Miyamoto H, Mori R, Taniguchi K, Matsuyama R, Akiyama H, Tanaka K, Ichikawa Y, Kato S, Kobayashi N, Kubota K, Nagashima Y, Goshima Y, Endo I.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S369-78. doi: 10.1245/s10434-012-2491-3. Epub 2012 Jul 18.

PMID:
22805864
[PubMed - indexed for MEDLINE]
15.

Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.

Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H.

Clin Cancer Res. 2008 Nov 1;14(21):7043-9. doi: 10.1158/1078-0432.CCR-08-0381.

PMID:
18981001
[PubMed - indexed for MEDLINE]
Free Article
16.

Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma.

Zhong X, Li M, Nie B, Wu F, Zhang L, Wang E, Han Y.

Ann Surg Oncol. 2013 Mar;20(3):1044-52. doi: 10.1245/s10434-012-2377-4. Epub 2012 May 17.

PMID:
22592183
[PubMed - indexed for MEDLINE]
17.

Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma.

Zhang J, Jiang X, Zhang J.

World J Surg Oncol. 2014 Mar 1;12:49. doi: 10.1186/1477-7819-12-49.

PMID:
24581082
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma.

An W, Ben QW, Chen HT, Zheng JM, Huang L, Li GX, Li ZS.

Ann Surg Oncol. 2012 Nov;19(12):3971-8. doi: 10.1245/s10434-012-2407-2. Epub 2012 May 24.

PMID:
22622471
[PubMed - indexed for MEDLINE]
19.

Beclin 1 expression is an independent prognostic factor for gastric carcinomas.

Yu M, Gou WF, Zhao S, Xiao LJ, Mao XY, Xing YN, Takahashi H, Takano Y, Zheng HC.

Tumour Biol. 2013 Apr;34(2):1071-83. doi: 10.1007/s13277-013-0648-8. Epub 2013 Jan 19.

PMID:
23334926
[PubMed - indexed for MEDLINE]
20.

Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma.

Zhang JJ, Zhu Y, Zhu Y, Wu JL, Liang WB, Zhu R, Xu ZK, Du Q, Miao Y.

Clin Transl Oncol. 2012 Feb;14(2):116-24. doi: 10.1007/s12094-012-0770-x.

PMID:
22301400
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk